Graviola in Metastatic Ovarian Cancer: A Case Report of Sustained Disease Stability
Corresponding AuthorThi Thuy Duong Pham
Concord Cancer Centre, Concord Repatriation General Hospital, NSW Australia
A B S T R A C T
Treatments for metastatic ovarian cancer to date have been limited by advanced stages at diagnosis, drug toxicity and resistance. Cancer patients are also increasingly looking towards complementary and alternative therapies. Graviola (Annona muricata) has traditionally been used in many conditions including cancer, and both in vivo and in vitro studies have shown evidence of anti-cancer effects. We present a case of a patient with metastatic ovarian cancer who progressed through multiple lines of chemotherapy but had a response and sustained stability in Ca-125 levels whilst taking graviola tablets. Further clinical research is warranted to evaluate graviola’s role in cancer therapy.
Article TypeCase Report
Publication historyReceived: Mon 04, Nov 2019
Accepted: Mon 18, Nov 2019
Published: Fri 29, Nov 2019
Copyright© 2021 Thi Thuy Duong Pham. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.